Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP168161.RA-B635CeLyOEDD7CDB1CmMLVB90sO4ogQiGqs8LAkgrQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP168161.RA-B635CeLyOEDD7CDB1CmMLVB90sO4ogQiGqs8LAkgrQ130_assertion type Assertion NP168161.RA-B635CeLyOEDD7CDB1CmMLVB90sO4ogQiGqs8LAkgrQ130_head.
- NP168161.RA-B635CeLyOEDD7CDB1CmMLVB90sO4ogQiGqs8LAkgrQ130_assertion description "[Subjects with the XRCC1 Gln/Gln genotype were inversely associated with adenoma risk (odds ratio, 0.6; 95% confidence interval, 0.4-0.9; P = 0.01) when compared with subjects with Arg/Arg and Arg/Gln genotypes combined.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP168161.RA-B635CeLyOEDD7CDB1CmMLVB90sO4ogQiGqs8LAkgrQ130_provenance.
- NP168161.RA-B635CeLyOEDD7CDB1CmMLVB90sO4ogQiGqs8LAkgrQ130_assertion evidence source_evidence_literature NP168161.RA-B635CeLyOEDD7CDB1CmMLVB90sO4ogQiGqs8LAkgrQ130_provenance.
- NP168161.RA-B635CeLyOEDD7CDB1CmMLVB90sO4ogQiGqs8LAkgrQ130_assertion SIO_000772 15767338 NP168161.RA-B635CeLyOEDD7CDB1CmMLVB90sO4ogQiGqs8LAkgrQ130_provenance.
- NP168161.RA-B635CeLyOEDD7CDB1CmMLVB90sO4ogQiGqs8LAkgrQ130_assertion wasDerivedFrom befree-20140225 NP168161.RA-B635CeLyOEDD7CDB1CmMLVB90sO4ogQiGqs8LAkgrQ130_provenance.
- NP168161.RA-B635CeLyOEDD7CDB1CmMLVB90sO4ogQiGqs8LAkgrQ130_assertion wasGeneratedBy ECO_0000203 NP168161.RA-B635CeLyOEDD7CDB1CmMLVB90sO4ogQiGqs8LAkgrQ130_provenance.